Beam-linked startup launches with an eye on the next generation of RNA drugs

Beam-linked startup launches with an eye on the next generation of RNA drugs

Source: 
BioPharma Dive
snippet: 

Orbital Therapeutics, a Cambridge, Mass.-based biotechnology startup focused on RNA-based medicines, launched Wednesday with a research collaboration with gene editing company Beam Therapeutics.